Sign in

CIK 0001534120 · Non-accelerated filer<br>Smaller reporting company

Avalo Therapeutics, Inc.

Sign in to watch
Ticker
AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
450705648
Phone
410-522-8707
Business address
1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
Former names
Cerecor Inc.
  1. 4 Shares withheld for taxes Chief Financial Officer gave up 138 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Medical Officer gave up 1,084 shares (to pay taxes)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Planned sale Chief Medical Officer sold 679 shares at $16.00 ($10,864)
  10. 4 Grant or award Chief Strategy Officer acquired 34,200 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 39,900 shares (grant or award)
  12. 4 Grant or award Chief Legal Officer acquired 24,300 shares (grant or award)
  13. 4 Grant or award Chief Medical Officer acquired 43,500 shares (grant or award)
  14. 4 Grant or award Chief Executive Officer acquired 100,200 shares (grant or award)
  15. 4 Planned sale Chief Medical Officer sold 3,000 shares at $18.76 ($56,280)
  16. 4 Planned sale Chief Financial Officer sold 18,606 shares at $24.12 ($448,818)
  17. 4 Planned sale Chief Legal Officer sold 75,063 shares at an average $20.17 ($1,513,673)
  18. 4 Planned sale Chief Financial Officer sold 47,000 shares at an average $20.19 ($948,722)
  19. 4 Planned sale Chief Medical Officer sold 108,234 shares at an average $20.61 ($2,230,367)
  20. 4 Planned sale Director sold 3,167 shares at $22.88 ($72,461)

Page 2 of 28 · 552 filings